We are live on
!
Find out more
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
13 hedge funds and large institutions have $130K invested in COSCIENS Biopharma Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
30% more funds holding
Funds holding: 10 → 13 (+3)
23% more capital invested
Capital invested by funds: $106K → $130K (+$24K)
0.68% more ownership
Funds ownership: 0.25% → 0.93% (+0.68%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$33.9K |
| 2 |
Morgan Stanley
New York
|
-$30.8K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$23.8K |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$8.76K |
| 5 |
JP Morgan Chase
New York
|
-$1.3K |
